Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will take steps to ensure equitable access to the anti-HIV drug PrEP for all groups who could benefit from it.

In March 2020, we announced that pre-exposure prophylaxis (PrEP) will be routinely available across England in 2020/21 as part of the Government’s aim to end HIV transmission by 2030. This year we provided £11 million to local authorities for routine commissioning of PrEP and this is already in place in the majority of areas. Routine commissioning of PrEP will benefit tens of thousands of people and, along with other measures, will take us closer to our ambition of zero HIV transmissions by 2030.

Public Health England, in collaboration with stakeholders, is currently developing a monitoring and evaluation framework for the routine commissioning of PrEP. This will use established surveillance systems and include measures of PrEP need and use among key population groups to inform equitable delivery and access.